avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pou2f2
|
ENSMUSG00000008496.12 | POU domain, class 2, transcription factor 2 |
Pou3f1
|
ENSMUSG00000090125.2 | POU domain, class 3, transcription factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Pou3f1 | mm10_v2_chr4_+_124657646_124657656 | -0.29 | 9.1e-02 | Click! |
Pou2f2 | mm10_v2_chr7_-_25132473_25132512 | 0.22 | 2.1e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.2 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
0.9 | 3.5 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.8 | 3.1 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
0.7 | 2.2 | GO:2000041 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.7 | 5.6 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.7 | 2.1 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
0.7 | 2.0 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.6 | 2.5 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.6 | 4.6 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.5 | 2.0 | GO:0060775 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
0.5 | 3.2 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.4 | 1.3 | GO:1904170 | regulation of bleb assembly(GO:1904170) |
0.4 | 4.5 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.4 | 2.2 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.4 | 1.7 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.4 | 4.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.4 | 44.3 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.3 | 0.7 | GO:1905066 | regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) |
0.3 | 3.8 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.3 | 3.4 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.3 | 1.0 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 3.6 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.3 | 0.9 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.3 | 3.9 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.3 | 1.1 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.3 | 1.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.2 | 1.0 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.2 | 25.8 | GO:0006342 | chromatin silencing(GO:0006342) |
0.2 | 1.7 | GO:0035799 | ureter maturation(GO:0035799) |
0.2 | 2.6 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 1.3 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.2 | 0.7 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.2 | 1.5 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 1.9 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.2 | 0.4 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.2 | 2.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 7.9 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 1.5 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.2 | 1.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 0.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.2 | 1.5 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 2.3 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 7.7 | GO:0006284 | base-excision repair(GO:0006284) |
0.2 | 0.3 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
0.2 | 3.8 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.2 | 0.5 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.2 | 6.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 1.9 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.1 | 0.3 | GO:0060435 | bronchiole development(GO:0060435) |
0.1 | 0.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 2.7 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 1.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.2 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.1 | 3.7 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 2.2 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 1.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 1.7 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 1.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 1.6 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 5.5 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.1 | 0.7 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 1.6 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 1.5 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 3.5 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.1 | 0.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.2 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.1 | 0.7 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.9 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.8 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 1.6 | GO:0060065 | uterus development(GO:0060065) |
0.1 | 0.3 | GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
0.1 | 0.8 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 0.2 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
0.1 | 4.6 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 1.7 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.1 | 0.6 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.1 | 0.6 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.1 | 0.3 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 2.5 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 2.2 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.3 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.1 | 0.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.2 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
0.0 | 0.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.5 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.0 | 0.1 | GO:1900247 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.0 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.5 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 1.3 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.0 | 1.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.1 | GO:0070342 | brown fat cell proliferation(GO:0070342) regulation of brown fat cell proliferation(GO:0070347) |
0.0 | 0.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.5 | GO:0021891 | olfactory bulb interneuron differentiation(GO:0021889) olfactory bulb interneuron development(GO:0021891) |
0.0 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.5 | GO:0050860 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.6 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 1.6 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.0 | 0.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.4 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.0 | 1.4 | GO:0051591 | response to cAMP(GO:0051591) |
0.0 | 0.7 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.9 | GO:0035307 | positive regulation of protein dephosphorylation(GO:0035307) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.2 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.0 | 0.4 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.0 | 2.4 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.1 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.0 | 0.7 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 1.5 | GO:0007338 | single fertilization(GO:0007338) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 7.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.6 | 47.6 | GO:0000786 | nucleosome(GO:0000786) |
0.4 | 3.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.4 | 8.4 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.3 | 1.3 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.2 | 1.5 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.2 | 2.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 1.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.4 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.1 | 1.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 3.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 1.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.4 | GO:0008623 | CHRAC(GO:0008623) |
0.1 | 0.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 1.9 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.1 | 1.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 1.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.7 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.2 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.1 | 0.4 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 21.9 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 1.0 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 1.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 3.9 | GO:0016605 | PML body(GO:0016605) |
0.0 | 3.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 1.5 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.5 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 3.6 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 1.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 1.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 2.9 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 6.4 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 1.3 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 1.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 2.1 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 0.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 1.7 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 7.9 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
1.3 | 6.7 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.9 | 3.8 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.8 | 7.7 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.7 | 5.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.7 | 2.0 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
0.4 | 2.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.4 | 1.5 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.4 | 3.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 3.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.3 | 1.9 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.3 | 2.1 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.3 | 1.3 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 3.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 2.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.2 | 6.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 1.7 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 2.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 1.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.2 | 0.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 0.6 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.2 | 1.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.2 | 0.6 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 0.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 1.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 2.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.6 | GO:0005220 | inositol hexakisphosphate binding(GO:0000822) inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 1.7 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 1.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.7 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.3 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.1 | 5.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 1.5 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 4.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.7 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 1.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 1.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.8 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 1.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 1.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 3.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 3.2 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 0.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.4 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 9.7 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 1.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 2.0 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 2.5 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.7 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.1 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.0 | 1.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 21.6 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.0 | 1.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 2.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 1.0 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 1.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.2 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 1.5 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 6.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 4.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 2.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 4.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 9.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 3.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 1.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 1.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 4.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 2.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 1.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 1.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 1.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 1.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 3.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.7 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 1.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 43.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
1.0 | 7.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 6.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 5.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 2.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 2.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 3.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 1.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 3.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 2.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 4.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 3.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 3.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 1.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 1.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.7 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 1.7 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 3.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.8 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 1.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 1.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 1.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 1.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.9 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 1.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |